Published on in CHOP News
For patients fighting sickle cell disease, finding compassionate care is part of the battle. A CHOP hematologist discusses the importance of caring for patients beyond the hospital.
Published on in CHOP News
A collaborative team of researchers, including Dr. Stephan Grupp, recently presented preliminary data showing that a CRISPR-based gene-editing therapy for inherited blood disorders is safe and effective.
Published on in CHOP News
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Published on in CHOP News
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Published on in CHOP News
Fears of catching Covid-19 in ERs forced many in the throes of pain crises to avoid seeking medical attention. Dr. Kim Smith-Whitley explains the importance of seeking care in a COVID-19 world.
Published on in CHOP News
Millions of Americans carry the sickle cell trait, many without knowing it. Could they be at risk for severe Covid-19? Stat News Reports.
Learn how Kim Smith-Whitley, MD, is fighting to improve the lives of her patients in the wake of COVID-19.
Read moreThe US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
Read morePublished on in CHOP in the Media
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Published on in Community Impact Report
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.